National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1159226

Government Disclaimer on use of this data

Case Details

VAERS ID: 1159226 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Michigan  
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Pharmacy       Purchased by: ?
Symptoms: Areflexia, Asthenia, Balance disorder, CSF protein increased, Guillain-Barre syndrome, Paraesthesia, White blood cell count increased
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Voltaren ointment
Current Illness:
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: CSF: protein of 184, WBC 23 (mostly mononuclear). The elevated CSF WBC is uncommon, but reported in AIDP/GBS.
CDC Split Type:

Write-up: Slowly progressive tingling, imbalance, and mild weakness, with loss of reflexes, elevated CSF protein, and slightly elevated WBC in CSF. Current diagnosis is probable AIDP/GBS (Guillain Barre Syndrome) beginning about 12 days after vaccination. EXAM: Mild weakness, imbalance, absent reflexes in legs, trace biceps reflexes

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166